Heidemarie Huber

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma.

Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: June 12, 2023

PRAME Is a Novel Target of Tumor-Intrinsic Gas6/Axl Activation and Promotes Cancer Cell Invasion in Hepatocellular Carcinoma.

PRAME Is a Novel Target of Tumor-Intrinsic Gas6/Axl Activation and Promotes Cancer Cell Invasion in Hepatocellular Carcinoma.

Journal: Cancers

Published: March 24, 2023

Gas6 in chronic liver disease-a novel blood-based biomarker for liver fibrosis.

Gas6 in chronic liver disease-a novel blood-based biomarker for liver fibrosis.

Journal: Cell death discovery

Published: November 25, 2022

Immunological Aspects of AXL/GAS-6 in the Context of Human Liver Regeneration.

Immunological Aspects of AXL/GAS-6 in the Context of Human Liver Regeneration.

Journal: Hepatology communications

Published: March 19, 2021

Transforming Growth Factor-β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma.

Transforming Growth Factor-β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma.

Journal: Hepatology (Baltimore, Md.)

Published: April 27, 2018

The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis.

The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis.

Journal: Cell death & disease

Published: June 02, 2017

Dynamics of CRISPR/Cas9-mediated genomic editing of the AXL locus in hepatocellular carcinoma cells.

Dynamics of CRISPR/Cas9-mediated genomic editing of the AXL locus in hepatocellular carcinoma cells.

Journal: Oncology letters

Published: May 11, 2017

Accurate Determination of Soluble Axl by Enzyme-Linked Immunosorbent Assay.

Accurate Determination of Soluble Axl by Enzyme-Linked Immunosorbent Assay.

Journal: Assay and drug development technologies

Published: November 03, 2016

Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.

Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.

Journal: Oncotarget

Published: September 01, 2016

Neuropilin-2 induced by transforming growth factor-β augments migration of hepatocellular carcinoma cells.

Neuropilin-2 induced by transforming growth factor-β augments migration of hepatocellular carcinoma cells.

Journal: BMC cancer

Published: May 08, 2015

Axl activates autocrine transforming growth factor-β signaling in hepatocellular carcinoma.

Axl activates autocrine transforming growth factor-β signaling in hepatocellular carcinoma.

Journal: Hepatology (Baltimore, Md.)

Published: June 27, 2014

PDGF enhances IRES-mediated translation of Laminin B1 by cytoplasmic accumulation of La during epithelial to mesenchymal transition.

PDGF enhances IRES-mediated translation of Laminin B1 by cytoplasmic accumulation of La during epithelial to mesenchymal transition.

Journal: Nucleic acids research

Published: August 21, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026